Sopharma - A company of growth - 3m 2014

A company of growth

24.5% revenue CAGR for the last decade. Stable global pharmaceuticals market growth of 3-4% and local market growth of 5% in 2012 and 7% in 2013. Major profit-drivers are the expected 80% increase in government healthcare spendings in order to reach the EU average and the aging domestic population.

  • 4078-2014-07-28-company-profile PDF 267.94 KB